IFC & Insurance Marketing’s CVS Health CVS Stock Holding History

IFC & Insurance Marketing’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-131	Closed	-$10K	–	184
2025 Q4	$10K	Buy	+131	New	+$10.3K	0.01%	391

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IFC & Insurance Marketing's CVS Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of CVS Health (CVS) in Q1 2026, closing a stake of 131 shares — an estimated $10K sold.

IFC & Insurance Marketing first reported a position in CVS in Q4 2025 and held it in 1 quarter. The position peaked at $10K in Q4 2025. 1,880 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

IFC & Insurance Marketing reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
IFC & Insurance Marketing sold 131 CVS Health shares in Q1 2026, an estimated $10K.
IFC & Insurance Marketing first reported a position in CVS Health in Q4 2025 and held it in 1 quarter.
IFC & Insurance Marketing's CVS Health position peaked at $10K in Q4 2025.
1,880 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.